Female | 48 years old
Currently there is no one specific cure for fibromyalgia, but education, lifestyle changes, and proper medications can help the individual to regain control and achieve significant improvement.
Models of pain behavior that interrelate biologic, cognitive, emotional, and behavioral variables form the basis for cognitive-behavioral and operant-behavioral approaches to adult pain management.
The researchers made a considerable progress in understanding fibromyalgia. Recent advances in their understanding of the fundamental mechanisms underlying fibromyalgia (FM) have shown that there is a significant peripheral neuropathic component to this disorder.
Methods for recognizing FM itself have been the subject of numerous reviews, and have generated at least two sets of formal, diagnostic criteria. Until recently, there has been little in the way of agreement as to nature and cause for the constellation of peripheral findings seen in this disorder. The robustness of the reports of small fiber neuropathy (SFN) in FM suggests that SFN is likely to be a fundamental component of this malady. Further, once the SFN is placed in context, there arises the inevitable conclusion that many of the symptoms seen in FM are likely to be immune-mediated. Additionally, ongoing work suggests that another important lesion, a large fiber neuropathy, exists in FM. In combination, all of these considerations provide a reasonable schematic for planning the treatment and monitoring of the painful complaints in this disorder.
Skin biopsy is a safe, minimally invasive, painless and cheap tool for providing diagnostic information on SFN, which are invisible to routine neurophysiological tests. Biopsy can be performed in hairy skin to investigate unmyelinated and thinly myelinated fibers and in glabrous skin to examine large myelinated fibers. Morphometric analysis of skin nerves is readily accomplished through the use of immunohistochemical techniques, and has proved to be reliable, reproducible and unaffected by the severity of neuropathy. One further advantage of skin biopsy over conventional nerve biopsy is that it allows somatic nerve fibers to be distinguished from autonomic nerve fibers. Skin biopsy is considered in patients with symptoms of small-fiber neuropathy when nerve conduction studies do not reveal abnormalities. Once SFN has been diagnosed, focused screening (e.g. glucose tolerance test) and treatment of neuropathic pain or fibromyalgia can begin. Skin biopsy provides an opportunity to identify subclinical involvement of autonomic nerve fibers and degeneration of somatic nerves in neuropathies otherwise considered exclusively autonomic, leading to a better comprehension of symptoms and awareness of potential complications.